MediClin AG (STU:MED) Shares Outstanding (EOP): 47.5 Mil (As of Mar. 2026)


STU:MED MediClin AG STU:MED
77 GF Score
Price €3.88
GF Value €2.93
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MediClin AG Shares Outstanding (EOP)?

MediClin AG STU:MED +1.04% 77 Shares Outstanding (EOP) is 47.5 Mil as of Mar. 2026. GuruFocus rates STU:MED with a GF Score™ of 77/100 and a GF Value™ of €2.93 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. MediClin AG's shares outstanding for the quarter that ended in Mar. 2026 was 47.5 Mil.

MediClin AG's quarterly shares outstanding stayed the same from Dec. 2025 (47.5 Mil) to Mar. 2026 (47.5 Mil).

MediClin AG's annual shares outstanding stayed the same from Dec. 2024 (47.5 Mil) to Dec. 2025 (47.5 Mil).


MediClin AG  (STU:MED) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


MediClin AG Shares Outstanding (EOP) Related Terms


MediClin AG Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for MediClin AG's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Shares Outstanding (EOP) Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.50 47.50 47.50 47.50 47.50

MediClin AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.50 47.50 47.50 47.50 47.50

STU:MED vs HCA, THC, DVA: Shares Outstanding (EOP) Comparison

For the Medical Care Facilities subindustry, MediClin AG's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where MediClin AG's Shares Outstanding (EOP) falls into.


STU:MED
77GF Score
MediClin AG STU:MED
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 47.5 Mil mean?
MediClin AG (STU:MED) has a Shares Outstanding (EOP) of 47.5 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on MediClin AG and its competitors.
Is MediClin AG's Shares Outstanding (EOP) too high?
MediClin AG's current Shares Outstanding (EOP) is 47.5 Mil. Overall, MediClin AG has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's Shares Outstanding (EOP) compare to HCA and THC?
MediClin AG's Shares Outstanding (EOP) of 47.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on MediClin AG and its competitors. MediClin AG's current Shares Outstanding (EOP) is 47.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (STU:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.93, compared to a current price of €3.88 — trading 32.4% above its estimated fair value. The current Shares Outstanding (EOP) is 47.5 Mil. MediClin AG's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For MediClin AG (STU:MED), the current Shares Outstanding (EOP) is 47.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (STU:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €3.88 is trading 32.4% above its estimated GF Value™ of €2.93. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for STU:MED:

  • Shares Outstanding (EOP): 47.5 Mil
  • GF Value™: €2.93 vs. price of €3.88 (32.4% above fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the STU:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UKMED:Germany
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
77GF Score

Get the complete analysis for STU:MED

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.88
Price
€2.93
GF Value